Error: Could not add to watchlist. X

NephroGenex Inc

+ Watchlist
NRX:US
NASDAQ CM
4.42
USD
0.06
1.38%
As of 20:10:00 ET on 08/01/2015.
Open
4.34
Day Range
4.23 - 4.44
Volume
15,721
Previous Close
4.36
52Wk Range
3.96 - 17.98
1 Yr Return
2.79%
Open
4.34
Day Range
4.23 - 4.44
Volume
15,721
Previous Close
4.36
52Wk Range
3.96 - 17.98
1 Yr Return
2.79%
YTD Return
-66.89%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.29
Market Cap (m USD)
45.807
Shares Outstanding (m)
10.364
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients.
ADDRESS
79 TW Alexander Drive
Building 4401, Suite290
Research Triangle Park, NC 27709-4188
United States
PHONE
1-609-986-1780
  • Pierre Legault
    Chief Executive Officer
  • J Wesley Fox
    President/Chief Scientific Ofcr
  • John P Hamill
    CFO/Treasurer/Secretary
  • Jaikrishna Patel
    Chief Medical Officer
Show More